in a double-blind , randomized , group-comparative clinical trial , 31 patients with acne vulgaris received topical treatment for 6-8 weeks with a lotion containing either 0.05 % retinoic acid or 0.1 % of the retinoic acid derivative ro 11-1430 .
C0001144
acne vulgaris
C0040845
retinoic acid